Old Web
English
Sign In
Acemap
>
authorDetail
>
Tony Crispino
Tony Crispino
Medicine
Pathology
Oncology
Internal medicine
Prostate cancer
6
Papers
103
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART II.
2020
The Journal of Urology
William T. Lowrance
Rodney H. Breau
Roger Chou
Brian F. Chapin
Tony Crispino
Robert Dreicer
David F. Jarrard
Adam S. Kibel
Todd M. Morgan
Alicia K. Morgans
William Oh
Matthew J. Resnick
Anthony L. Zietman
Michael S. Cookson
Show All
Source
Cite
Save
Citations (36)
The Movember Prostate Cancer Landscape Analysis: an assessment of unmet research needs.
2020
Nature Reviews Urology
Michelle M. Kouspou
Jenna E. Fong
Nadine Brew
Sarah T. F. Hsiao
Seanna L. Davidson
Peter L. Choyke
Tony Crispino
Suneil Jain
Guido Jenster
Beatrice S. Knudsen
Jeremy L. Millar
Nicole Mittmann
Charles J. Ryan
Bertrand Tombal
Mark Buzza
Show All
Source
Cite
Save
Citations (6)
Molecular Biomarkers in Localized Prostate Cancer: ASCO Guideline.
2019
Journal of Clinical Oncology
Scott E. Eggener
R. Bryan Rumble
Andrew J. Armstrong
Todd M. Morgan
Tony Crispino
Philip Cornford
Theodorus van der Kwast
David J. Grignon
Alex J. Rai
Neeraj Agarwal
Eric A. Klein
Robert B. Den
Himisha Beltran
Show All
Source
Cite
Save
Citations (56)
Circulating tumor cells (CTCs) in SWOG S1216: A phase 3 multicenter trial in metastatic hormone sensitive prostate cancer (mHSPC).
2016
Journal of Clinical Oncology
Amir Goldkorn
Melissa Plets
Neeraj Agarwal
Maha Hussain
Primo N. Lara
Daniel A. Vaena
Gary R. MacVicar
Tony Crispino
A. L. Harzstark
Przemyslaw Twardowski
Catherine M. Tangen
Cory M. Hugen
Tong Xu
Yucheng Xu
Jacek Pinski
Sue A. Ingles
Celestia S. Higano
Nicholas J. Vogelzang
Ian M. Thompson
David I. Quinn
Show All
Source
Cite
Save
Citations (4)
SWOG S1216: A phase III randomized trial comparing androgen deprivation therapy (ADT) plus TAK-700 with ADT plus bicalutamide in patients with newly diagnosed metastatic hormone-sensitive prostate cancer (HSPC) (NCT01809691).
2014
Journal of Clinical Oncology
Neeraj Agarwal
Catherine M. Tangen
Maha Hussain
Primo N. Lara
Celestia S. Higano
Daniel A. Vaena
Gary R. MacVicar
Hongli Li
Tony Crispino
David I. Quinn
Nicholas J. Vogelzang
Ian M. Thompson
Show All
Source
Cite
Save
Citations (0)
1